Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks
Open Access
- 1 August 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 31 (15) , 4373-4384
Abstract
Topoisomerase II is a ubiquitous enzyme that removes knots and tangles from the genetic material by generating transient double‐strand DNA breaks. While the enzyme cannot perform its essential cellular functions without cleaving DNA, this scission activity is inherently dangerous to chromosomal integrity. In fact, etoposide and other clinically important anticancer drugs kill cells by increasing levels of topoisomerase II‐mediated DNA breaks. Cells rely heavily on recombination to repair double‐strand DNA breaks, but the specific pathways used to repair topoisomerase II‐generated DNA damage have not been defined. Therefore, Saccharomyces cerevisiae was used as a model system to delineate the recombination pathways that repair DNA breaks generated by topoisomerase II. Yeast cells that expressed wild‐type or a drug‐hypersensitive mutant topoisomerase II or overexpressed the wild‐type enzyme were examined. Based on cytotoxicity and recombination induced by etoposide in different repair‐deficient genetic backgrounds, double‐strand DNA breaks generated by topoisomerase II appear to be repaired primarily by the single‐strand invasion pathway of homologous recombination. Non‐homologous end joining also was triggered by etoposide treatment, but this pathway was considerably less active than single‐strand invasion and did not contribute significantly to cell survival in S.cerevisiae.Keywords
This publication has 89 references indexed in Scilit:
- Double-strand-break-induced homologous recombination in mammalian cellsBiochemical Society Transactions, 2001
- Recombination: a frank view of exchanges and vice versaCurrent Opinion in Cell Biology, 2000
- A truncated cytoplasmic topoisomerase IIα in a drug-resistant lung cancer cell line is encoded by aTOP2A allele with a partial deletion of exon 34International Journal of Cancer, 2000
- Role of recombinational repair in sensitivity to an antitumour agent that inhibits bacteriophage T4 type II DNA topoisomeraseMolecular Microbiology, 1996
- Effects of topoisomerase II inhibition in lymphoblasts from patients with progeroid and “chromosome instability” syndromesCancer Genetics and Cytogenetics, 1996
- A Mutation in Yeast TOP2 Homologous to a Quinolone-resistant Mutation in BacteriaJournal of Biological Chemistry, 1995
- Small Deletion and Insertion Mutations Induced by the Topoisomerase II Inhibitor Teniposide in CHO Cells and Comparison with Sites of Drug-stimulated DNA Cleavage in VitroJournal of Molecular Biology, 1993
- Quinolone Mode of Action - New Aspects†Drugs, 1993
- Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factorsCancer Treatment Reviews, 1990
- Establishment and Characterization of Resistant Cells to Etoposide (VP16) from a Mouse Breast Cancer Cell Line, FM3AJapanese Journal of Cancer Research, 1988